Canada markets closed

Vincerx Pharma, Inc. (VINC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8892+0.0622 (+7.52%)
At close: 04:00PM EDT
0.8500 -0.04 (-4.41%)
After hours: 07:45PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
28,973
28,973
49,837
40,081
7,116
Selling General and Administrative
13,636
13,636
18,885
22,575
3,598
Total Operating Expenses
42,609
42,609
68,722
62,656
10,714
Operating Income or Loss
-42,609
-42,609
-68,722
-62,656
-10,714
Interest Expense
-
-
-
-
8
Total Other Income/Expenses Net
1,201
1,201
5,074
23,350
-5,144
Income Before Tax
-40,157
-40,157
-62,984
-39,306
-16,620
Income from Continuing Operations
-40,157
-40,157
-62,984
-39,306
-16,620
Net Income
-40,157
-40,157
-62,984
-39,306
-16,620
Net Income available to common shareholders
-40,157
-40,157
-62,984
-39,306
-16,620
Basic EPS
-2.31
-
-3.00
-2.29
-3.16
Diluted EPS
-2.31
-
-3.00
-2.29
-3.16
Basic Average Shares
21,237
-
21,029
17,176
5,252
Diluted Average Shares
21,237
-
21,029
17,176
5,252